Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benacof is a brand of over-the-counter (OTC) medications developed and manufactured by Taj Pharmaceuticals for the treatment of cold, cough, and allergy symptoms. The product line includes several distinct formulations: a single-ingredient diphenhydramine capsule for allergies and sleep; a multi-ingredient tablet containing caffeine, cetirizine, nimesulide, paracetamol, and phenylephrine; "Benacof Cold" tablets containing cetirizine, paracetamol, and phenylephrine; and a cough syrup containing chlorpheniramine, phenylephrine, and dextromethorphan. These formulations utilize small molecule active ingredients that act as antihistamines (H1 receptor antagonists), analgesics/antipyretics (COX inhibitors), decongestants (alpha-adrenergic agonists), and antitussives (NMDA receptor antagonists). The products are primarily marketed in India for domestic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Benacof.